{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:04:43Z","timestamp":1780113883598,"version":"3.54.0"},"reference-count":58,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,5,26]]},"DOI":"10.1248\/bpb.b26-00103","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T22:11:02Z","timestamp":1779747062000},"page":"852-862","source":"Crossref","is-referenced-by-count":0,"title":["Aromatic-Turmerone Analogs Activate Chaperone-Mediated Autophagy and Ameliorate Dendritic Shrinkage in Purkinje Cell Models of Spinocerebellar Ataxia"],"prefix":"10.1248","volume":"49","author":[{"given":"Kensuke","family":"Motomura","sequence":"first","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5\u20131 Oe-Honmachi, Chuo-ku, Kumamoto 862\u20130973, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ueda-Ishizaka","sequence":"additional","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5\u20131 Oe-Honmachi, Chuo-ku, Kumamoto 862\u20130973, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Boateng","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Neurophysiology &amp; Neural Repair, Gunma University Graduate School of Medicine, 3\u201339\u201322 Showa-machi, Maebashi, Gunma 371\u20138511, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Yabuki","sequence":"additional","affiliation":[{"name":"Department of Genomic Neurology, Institute of Molecular Embryology and Genetics (IMEG) and Graduate School of Pharmaceutical Sciences, Kumamoto University, 2\u20132\u20131 Honjo, Chuo-ku, Kumamoto 860\u20130811, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Hitora-Imamura","sequence":"additional","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5\u20131 Oe-Honmachi, Chuo-ku, Kumamoto 862\u20130973, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kurauchi","sequence":"additional","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5\u20131 Oe-Honmachi, Chuo-ku, Kumamoto 862\u20130973, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Shioda","sequence":"additional","affiliation":[{"name":"Department of Genomic Neurology, Institute of Molecular Embryology and Genetics (IMEG) and Graduate School of Pharmaceutical Sciences, Kumamoto University, 2\u20132\u20131 Honjo, Chuo-ku, Kumamoto 860\u20130811, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satohiro","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, 7\u20132\u20131 Kamiohno, Himeji, Hyogo 670\u20138524, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Neurophysiology &amp; Neural Repair, Gunma University Graduate School of Medicine, 3\u201339\u201322 Showa-machi, Maebashi, Gunma 371\u20138511, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Katsuki","sequence":"additional","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5\u20131 Oe-Honmachi, Chuo-ku, Kumamoto 862\u20130973, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9894-4768","authenticated-orcid":false,"given":"Takahiro","family":"Seki","sequence":"additional","affiliation":[{"name":"Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5\u20131 Oe-Honmachi, Chuo-ku, Kumamoto 862\u20130973, Japan"},{"name":"Department of Pharmacology, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, 7\u20132\u20131 Kamiohno, Himeji, Hyogo 670\u20138524, Japan"},{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Rudaks LI, Yeow D, Ng K, Deveson IW, Kennerson ML, Kumar KR. An update on the adult-onset hereditary cerebellar ataxias: novel genetic causes and new diagnostic approaches. <i>Cerebellum<\/i>, <b>23<\/b>, 2152\u20132168 (2024).","DOI":"10.1007\/s12311-024-01703-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. <i>Nat. Rev. Dis. Primers<\/i>, <b>5<\/b>, 24 (2019).","DOI":"10.1038\/s41572-019-0074-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Watson LM, Wong MMK, Becker EBE. Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia. <i>Open Biol.<\/i>, <b>5<\/b>, 150056 (2015).","DOI":"10.1098\/rsob.150056"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Shakkottai VG, do Carmo Costa M, Dell\u2019Orco JM, Sankaranarayanan A, Wulff H, Paulson HL. Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3. <i>J. Neurosci.<\/i>, <b>31<\/b>, 13002\u201313014 (2011).","DOI":"10.1523\/JNEUROSCI.2789-11.2011"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Watanave M, Hoshino C, Konno A, Fukuzaki Y, Matsuzaki Y, Ishitani T, Hirai H. Pharmacological enhancement of retinoid-related orphan receptor \u03b1 function mitigates spinocerebellar ataxia type 3 pathology. <i>Neurobiol. Dis.<\/i>, <b>121<\/b>, 263\u2013273 (2019).","DOI":"10.1016\/j.nbd.2018.10.014"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ohta T, Morikawa Y, Sato M, Konno A, Hirai H, Kurauchi Y, Hisatsune A, Katsuki H, Seki T. Therapeutic potential of D-cysteine against <i>in vitro<\/i> and <i>in vivo<\/i> models of spinocerebellar ataxia. <i>Exp. Neurol.<\/i>, <b>343<\/b>, 113791 (2021).","DOI":"10.1016\/j.expneurol.2021.113791"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Irie T, Matsuzaki Y, Sekino Y, Hirai H. Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells. <i>J. Physiol.<\/i>, <b>592<\/b>, 229\u2013247 (2014).","DOI":"10.1113\/jphysiol.2013.264309"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Seki T, Shimahara T, Yamamoto K, Abe N, Amano T, Adachi N, Takahashi H, Kashiwagi K, Saito N, Sakai N. Mutant \u03b3PKC found in spinocerebellar ataxia type 14 induces aggregate-independent maldevelopment of dendrites in primary cultured Purkinje cells. <i>Neurobiol. Dis.<\/i>, <b>33<\/b>, 260\u2013273 (2009).","DOI":"10.1016\/j.nbd.2008.10.013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Seki T, Sato M, Kibe Y, Ohta T, Oshima M, Konno A, Hirai H, Kurauchi Y, Hisatsune A, Katsuki H. Lysosomal dysfunction and early glial activation are involved in the pathogenesis of spinocerebellar ataxia type 21 caused by mutant transmembrane protein 240. <i>Neurobiol. Dis.<\/i>, <b>120<\/b>, 34\u201350 (2018).","DOI":"10.1016\/j.nbd.2018.08.022"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Trelford CB, Di Guglielmo GM. Molecular mechanisms of mammalian autophagy. <i>Biochem. J.<\/i>, <b>478<\/b>, 3395\u20133421 (2021).","DOI":"10.1042\/BCJ20210314"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Schnebert S, Goguet M, V\u00e9lez EJ, Depinc\u00e9 A, Beaumatin F, Herpin A, Seiliez I. Diving into the evolutionary history of HSC70-linked selective autophagy pathways: endosomal microautophagy and chaperone-mediated autophagy. <i>Cells<\/i>, <b>11<\/b>, 1945 (2022).","DOI":"10.3390\/cells11121945"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Seki T, Yoshino KI, Tanaka S, Dohi E, Onji T, Yamamoto K, Hide I, Paulson HL, Saito N, Sakai N. Establishment of a novel fluorescence-based method to evaluate chaperone-mediated autophagy in a single neuron. <i>PLOS ONE<\/i>, <b>7<\/b>, e31232 (2012).","DOI":"10.1371\/journal.pone.0031232"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sato M, Ohta T, Morikawa Y, Konno A, Hirai H, Kurauchi Y, Hisatsune A, Katsuki H, Seki T. Ataxic phenotype and neurodegeneration are triggered by the impairment of chaperone-mediated autophagy in cerebellar neurons. <i>Neuropathol. Appl. Neurobiol.<\/i>, <b>47<\/b>, 198\u2013209 (2021).","DOI":"10.1111\/nan.12649"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kim JH, Lukowicz A, Qu W, Johnson A, Cvetanovic M. Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage-of-disease specific manner. <i>Glia<\/i>, <b>66<\/b>, 1972\u20131987 (2018).","DOI":"10.1002\/glia.23451"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Cvetanovic M, Ingram M, Orr H, Opal P. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. <i>Neuroscience<\/i>, <b>289<\/b>, 289\u2013299 (2015).","DOI":"10.1016\/j.neuroscience.2015.01.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Aikawa T, Mogushi K, Iijima-Tsutsui K, Ishikawa K, Sakurai M, Tanaka H, Mizusawa H, Watase K. Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model. <i>Hum. Mol. Genet.<\/i>, <b>24<\/b>, 4780\u20134791 (2015).","DOI":"10.1093\/hmg\/ddv202"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ueda E, Ohta T, Konno A, Hirai H, Kurauchi Y, Katsuki H, Seki T. D-cysteine activates chaperone-mediated autophagy in cerebellar Purkinje cells <i>via<\/i> the generation of hydrogen sulfide and Nrf2 activation. <i>Cells<\/i>, <b>11<\/b>, 1230 (2022).","DOI":"10.3390\/cells11071230"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Roth GN, Chandra A, Nair MG. Novel bioactivities of <i>Curcuma longa<\/i> constituents. <i>J. Nat. Prod.<\/i>, <b>61<\/b>, 542\u2013545 (1998).","DOI":"10.1021\/np970459f"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Park SY, Jin ML, Kim YH, Kim Y, Lee SJ. Anti-inflammatory effects of aromatic-turmerone through blocking of NF-\u03baB, JNK, and p38 MAPK signaling pathways in amyloid \u03b2-stimulated microglia. <i>Int. Immunopharmacol.<\/i>, <b>14<\/b>, 13\u201320 (2012).","DOI":"10.1016\/j.intimp.2012.06.003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Park SY, Kim YH, Kim Y, Lee SJ. Aromatic-turmerone\u2019s anti-inflammatory effects in microglial cells are mediated by protein kinase A and heme oxygenase-1 signaling. <i>Neurochem. Int.<\/i>, <b>61<\/b>, 767\u2013777 (2012).","DOI":"10.1016\/j.neuint.2012.06.020"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Chen M, Chang YY, Huang S, Xiao LH, Zhou W, Zhang LY, Li C, Zhou RP, Tang J, Lin L, Du ZY, Zhang K. Aromatic-turmerone attenuates LPS-induced neuroinflammation and consequent memory impairment by targeting TLR4-dependent signaling pathway. <i>Mol. Nutr. Food Res.<\/i>, <b>62<\/b>, 1700281 (2018).","DOI":"10.1002\/mnfr.201700281"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hucklenbroich J, Klein R, Neumaier B, Graf R, Fink GR, Schroeter M, Rueger MA. Aromatic-turmerone induces neural stem cell proliferation <i>in vitro<\/i> and <i>in vivo<\/i>. <i>Stem Cell Res. Ther.<\/i>, <b>5<\/b>, 100 (2014).","DOI":"10.1186\/scrt500"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hori Y, Tsutsumi R, Nasu K, Boateng A, Ashikari Y, Sugiura M, Nakajima M, Kurauchi Y, Hisatsune A, Katsuki H, Seki T. Aromatic-turmerone analogs protect dopaminergic neurons in midbrain slice cultures through their neuroprotective activities. <i>Cells<\/i>, <b>10<\/b>, 1090 (2021).","DOI":"10.3390\/cells10051090"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Pajares M, Rojo AI, Arias E, D\u00edaz-Carretero A, Cuervo AM, Cuadrado A. Transcription factor NFE2L2\/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A. <i>Autophagy<\/i>, <b>14<\/b>, 1310\u20131322 (2018).","DOI":"10.1080\/15548627.2018.1474992"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Motomura K, Ueda E, Boateng A, Sugiura M, Kadoyama K, Hitora-Imamura N, Kurauchi Y, Katsuki H, Seki T. Identification of a novel aromatic-turmerone analog that activates chaperone-mediated autophagy through the persistent activation of p38. <i>Front. Cell Dev. Biol.<\/i>, <b>12<\/b>, 1418296 (2024).","DOI":"10.3389\/fcell.2024.1418296"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Sato M, Seki T, Konno A, Hirai H, Kurauchi Y, Hisatsune A, Katsuki H. Fluorescent-based evaluation of chaperone-mediated autophagy and microautophagy activities in cultured cells. <i>Genes Cells<\/i>, <b>21<\/b>, 861\u2013873 (2016).","DOI":"10.1111\/gtc.12390"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Huda F, Konno A, Matsuzaki Y, Goenawan H, Miyake K, Shimada T, Hirai H. Distinct transduction profiles in the CNS <i>via<\/i> three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model. <i>Mol. Ther. Methods Clin. Dev.<\/i>, <b>1<\/b>, 14032 (2014).","DOI":"10.1038\/mtm.2014.32"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Morikawa-Yujiri Y, Motomura K, Konno A, Hitora-Imamura N, Kurauchi Y, Masuda S, Hirai H, Katsuki H, Seki T. Establishment of spinocerebellar ataxia type 34 model mice accompanied by early glial activation and degeneration of cerebellar neurons. <i>J. Pharmacol. Sci<\/i>., <b>161<\/b>, 64\u201378 (2026).","DOI":"10.1016\/j.jphs.2026.04.004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Du X, Wang J, Zhu H, Rinaldo L, Lamar KM, Palmenberg AC, Hansel C, Gomez CM. Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6. <i>Cell<\/i>, <b>154<\/b>, 118\u2013133 (2013).","DOI":"10.1016\/j.cell.2013.05.059"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Seki T, Sato M, Konno A, Hirai H, Kurauchi Y, Hisatsune A, Katsuki H. D-Cysteine promotes dendritic development in primary cultured cerebellar Purkinje cells <i>via<\/i> hydrogen sulfide production. <i>Mol. Cell. Neurosci.<\/i>, <b>93<\/b>, 36\u201347 (2018).","DOI":"10.1016\/j.mcn.2018.10.002"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kovalevich J, Langford D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. <i>Methods Mol. Biol.<\/i>, <b>1078<\/b>, 9\u201321 (2013).","DOI":"10.1007\/978-1-62703-640-5_2"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Lin MH, Yen JH, Weng CY, Wang L, Ha CL, Wu MJ. Lipid peroxidation end product 4-hydroxy-<i>trans<\/i>-2-nonenal triggers unfolded protein response and heme oxygenase-1 expression in PC12 cells: Roles of ROS and MAPK pathways. <i>Toxicology<\/i>, <b>315<\/b>, 24\u201337 (2014).","DOI":"10.1016\/j.tox.2013.11.007"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Meng Y, Feng R, Yang Z, Liu T, Huo T, Jiang H. Oxidative stress induced by realgar in neurons: p38 MAPK and ERK1\/2 perturb autophagy and induce the p62-Keap1-Nrf2 feedback loop to activate the Nrf2 signalling pathway. <i>J. Ethnopharmacol.<\/i>, <b>282<\/b>, 114582 (2022).","DOI":"10.1016\/j.jep.2021.114582"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Meng XB, Sun GB, Wang M, Sun J, Qin M, Sun XB. P90RSK and Nrf2 activation <i>via<\/i> MEK1\/2-ERK1\/2 pathways mediated by notoginsenoside R2 to prevent 6-hydroxydopamine-induced apoptotic death in SH-SY5Y cells. <i>Evid. Based Complement. Alternat. Med.<\/i>, <b>2013<\/b>, 971712 (2013).","DOI":"10.1155\/2013\/971712"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Zanjani HS, Lohof AM, McFarland R, Vogel MW, Mariani J. Enhanced survival of wild-type and Lurcher Purkinje cells <i>in vitro<\/i> following inhibition of conventional PKCs or stress-activated MAP kinase pathways. <i>Cerebellum<\/i>, <b>12<\/b>, 377\u2013389 (2013).","DOI":"10.1007\/s12311-012-0427-x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Repici M, Wehrl\u00e9 R, Antoniou X, Borsello T, Dusart I. c-Jun N-terminal kinase (JNK) and p38 play different roles in age-related Purkinje cell death in murine organotypic culture. <i>Cerebellum<\/i>, <b>10<\/b>, 281\u2013290 (2011).","DOI":"10.1007\/s12311-010-0244-z"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Homma H, Yoshioka Y, Fujita K, Shirai S, Hama Y, Komano H, Saito Y, Yabe I, Okano H, Sasaki H, Tanaka H, Okazawa H. Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage. <i>Commun. Biol.<\/i>, <b>7<\/b>, 413 (2024).","DOI":"10.1038\/s42003-024-06066-z"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, Muguruma K. Vulnerability of Purkinje cells generated from spinocerebellar ataxia type 6 patient-derived iPSCs. <i>Cell Rep.<\/i>, <b>17<\/b>, 1482\u20131490 (2016).","DOI":"10.1016\/j.celrep.2016.10.026"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) van der Heijden ME, Sillitoe RV. Interactions between Purkinje cells and granule cells coordinate the development of functional cerebellar circuits. <i>Neuroscience<\/i>, <b>462<\/b>, 4\u201321 (2021).","DOI":"10.1016\/j.neuroscience.2020.06.010"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Cerminara NL, Lang EJ, Sillitoe RV, Apps R. Redefining the cerebellar cortex as an assembly of non-uniform Purkinje cell microcircuits. <i>Nat. Rev. Neurosci.<\/i>, <b>16<\/b>, 79\u201393 (2015).","DOI":"10.1038\/nrn3886"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Kirchner P, Bourdenx M, Madrigal-Matute J, Tiano S, Diaz A, Bartholdy BA, Will B, Cuervo AM. Proteome-wide analysis of chaperone-mediated autophagy targeting motifs. <i>PLoS Biol.<\/i>, <b>17<\/b>, e3000301 (2019).","DOI":"10.1371\/journal.pbio.3000301"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Seki T, Katsuki H. <i>Mammalian microautophagy: mechanism and roles in disease in Autophagy Health and Disease 2nd edition<\/i>. (Rothermel BA, Diwan A eds.) Elsevier, Amsterdam, Netherlands, pp. 385\u2013397 (2021).","DOI":"10.1016\/B978-0-12-822003-0.00027-9"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Cuervo AM, Dice JF. Age-related decline in chaperone-mediated autophagy. <i>J. Biol. Chem.<\/i>, <b>275<\/b>, 31505\u201331513 (2000).","DOI":"10.1074\/jbc.M002102200"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Agbaga MP, Brush RS, Mandal MNA, Henry K, Elliott MH, Anderson RE. Role of stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>105<\/b>, 12843\u201312848 (2008).","DOI":"10.1073\/pnas.0802607105"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Gyening YK, Chauhan NK, Tytanic M, Ea V, Brush RS, Agbaga MP. ELOVL4 mutations that cause spinocerebellar ataxia-34 differentially alter very long chain fatty acid biosynthesis. <i>J. Lipid Res<\/i>., <b>64<\/b>, 100317 (2023).","DOI":"10.1016\/j.jlr.2022.100317"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Cheng V, Rallabandi R, Gorusupudi A, Lucas S, Rognon G, Bernstein PS, Rainier JD, Conboy JC. Influence of very-long-chain polyunsaturated fatty acids on membrane structure and dynamics. <i>Biophys. J.<\/i>, <b>121<\/b>, 2730\u20132741 (2022).","DOI":"10.1016\/j.bpj.2022.06.015"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Kanno H, Handa K, Murakami T, Aizawa T, Ozawa H. Chaperone-mediated autophagy in neurodegenerative diseases and acute neurological insults in the central nervous system. <i>Cells<\/i>, <b>11<\/b>, 1205 (2022).","DOI":"10.3390\/cells11071205"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Xu X, Sun Y, Cen X, Shan B, Zhao Q, Xie T, Wang Z, Hou T, Xue Y, Zhang M, Peng D, Sun Q, Yi C, Najafov A, Xia H. Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model. <i>Protein Cell<\/i>, <b>12<\/b>, 769\u2013787 (2021).","DOI":"10.1007\/s13238-021-00858-3"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Sreenivasmurthy SG, Iyaswamy A, Krishnamoorthi S, Reddi RN, Kammala AK, Vasudevan K, Senapati S, Zhu Z, Su CF, Liu J, Guan XJ, Chua KK, Cheung KH, Chen H, Zhang HJ, Zhang Y, Song JX, Kumar Durairajan SS, Li M. Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer\u2019s disease therapy. <i>Front. Mol. Biosci.<\/i>, <b>9<\/b>, 1030534 (2022).","DOI":"10.3389\/fmolb.2022.1030534"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Bourdenx M, Mart\u00edn-Segura A, Scrivo A, <i>et al<\/i>. Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome. <i>Cell<\/i>, <b>184<\/b>, 2696\u20132714.e25 (2021).","DOI":"10.1016\/j.cell.2021.03.048"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy. <i>Science<\/i>, <b>305<\/b>, 1292\u20131295 (2004).","DOI":"10.1126\/science.1101738"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R, Wu DC, Follenzi A, Dauer W, Przedborski S, Ischiropoulos H, Lansbury PT, Sulzer D, Cuervo AM. Dopamine-modified \u03b1-synuclein blocks chaperone-mediated autophagy. <i>J. Clin. Invest.<\/i>, <b>118<\/b>, 777\u2013788 (2008).","DOI":"10.1172\/JCI32806"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, Schapira AHV. Chaperone-mediated autophagy markers in Parkinson Disease Brains. <i>Arch. Neurol.<\/i>, <b>67<\/b>, 1464\u20131472 (2010).","DOI":"10.1001\/archneurol.2010.198"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Sala G, Stefanoni G, Arosio A, Riva C, Melchionda L, Saracchi E, Fermi S, Brighina L, Ferrarese C. Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson\u2019s disease. <i>Brain Res.<\/i>, <b>1546<\/b>, 46\u201352 (2014).","DOI":"10.1016\/j.brainres.2013.12.017"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Arosio A, Cristofani R, Pansarasa O, Crippa V, Riva C, Sirtori R, Rodriguez-Menendez V, Riva N, Gerardi F, Lunetta C, Cereda C, Poletti A, Ferrarese C, Tremolizzo L, Sala G. HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation. <i>Amyotroph. Lateral Scler. Frontotemporal Degener.<\/i>, <b>21<\/b>, 51\u201362 (2020).","DOI":"10.1080\/21678421.2019.1672749"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Orme\u00f1o F, Hormazabal J, Moreno J, Riquelme F, Rios J, Criollo A, Albornoz A, Alfaro IE, Budini M. Chaperone mediated autophagy degrades TDP-43 protein and is affected by TDP-43 aggregation. <i>Front. Mol. Neurosci.<\/i>, <b>13<\/b>, 19 (2020).","DOI":"10.3389\/fnmol.2020.00019"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Idera A, Sharkey LM, Kurauchi Y, Kadoyama K, Paulson HL, Katsuki H, Seki T. Wild-type and pathogenic forms of ubiquilin 2 differentially modulate components of the autophagy-lysosome pathways. <i>J. Pharmacol. Sci.<\/i>, <b>152<\/b>, 182\u2013192 (2023).","DOI":"10.1016\/j.jphs.2023.05.002"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Oh KN, Bae D, Oh DR, Hong JA, Kim Y, Kim E, Son SA, Lee KY, Kim S. TLR4\/NF-\u03baB-mediated anti-inflammatory and cognitive protective actions of <i>Curcuma longa<\/i> and Ar-turmerone in Alzheimer\u2019s disease models. <i>J. Microbiol. Biotechnol.<\/i>, <b>35<\/b>, e2506044\u201316 (2025).","DOI":"10.4014\/jmb.2506.06044"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/5\/49_b26-00103\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:39:13Z","timestamp":1780112353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/5\/49_b26-00103\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00103","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"b26-00103"}}